Literature DB >> 16643132

Adherence to treatment in patients with psoriasis.

H L Richards1, D G Fortune, C E M Griffiths.   

Abstract

Non-adherence to medication is a chronic problem that impacts on healthcare professionals and patients alike. In psoriasis, a condition that presents patients with frequent and disabling physical, psychological and social effects, studies consistently suggest that up to 40% of patients do not use their medication as directed. Thus it is probable that poor adherence contaminates the clinical picture of response effectiveness in everyday practice. This educational paper reviews research that investigates adherence to medication in patients with psoriasis. It provides an overview of contributing factors and mediating variables. It is proposed that three specific facets appear to optimize patient adherence: an effective doctor-patient relationship; optimism with the treatment prescribed; and a limited 'nuisance' value of treatment in terms of side-effects and hassle of use. Various strategies to address adherence are suggested and it is argued that in order to enhance our understanding of adherence in patients with psoriasis, there needs to be an increasing focus on patients' beliefs about their condition and its management.

Entities:  

Mesh:

Year:  2006        PMID: 16643132     DOI: 10.1111/j.1468-3083.2006.01565.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  26 in total

Review 1.  [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].

Authors:  J Schmitt; M Meurer
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

Review 2.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

3.  Eliciting preferences to inform patient-centred policies: the case of psoriasis.

Authors:  Aleksandra Torbica; Giovanni Fattore; Fabio Ayala
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

4.  Microsphere technology: hype or help?

Authors:  Leon H Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

Review 5.  The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Authors:  Steven R Feldman; Bernard Goffe; Gary Rice; Matthew Mitchell; Mandeep Kaur; Debbie Robertson; Debra Sierka; Jeffrey A Bourret; Tamara S Evans; Alice Gottlieb
Journal:  Am Health Drug Benefits       Date:  2016-12

6.  Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05.

Authors:  Joseph F Fowler; James Q Del Rosso; Refika I Pakunlu; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

7.  Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.

Authors:  Dean G Cruess; A Russell Localio; Alec B Platt; Colleen M Brensinger; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Stephen E Kimmel
Journal:  Int J Behav Med       Date:  2010-03

8.  A systematic review of evidence on the links between patient experience and clinical safety and effectiveness.

Authors:  Cathal Doyle; Laura Lennox; Derek Bell
Journal:  BMJ Open       Date:  2013-01-03       Impact factor: 2.692

9.  Drug focus: adalimumab in the treatment of moderate to severe psoriasis.

Authors:  Gino A Vena; Nicoletta Cassano
Journal:  Biologics       Date:  2007-06

10.  Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

Authors:  Sandra Swimberghe; Pierre-Dominique Ghislain; Evis Daci; Katrien Allewaert; Kris Denhaerynck; Christine Hermans; Christy Pacheco; Stefaan Vancayzeele; Karen Macdonald; Ivo Abraham
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.